Jim Simons G1 Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

$63.6 Billion
Q1 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in G1 Therapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 903,700 shares of GTHX stock, worth $2.06 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

903,700

Previous 630,400 43.35%

Holding current value

$2.06 Million

Previous $1.92 Million 103.02%

% of portfolio

0.01%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$2.1 - $4.83 $573,930 - $1.32 Million	273,300 Added 43.35%	903,700 $3.9 Million
Q4 2023 Feb 13, 2024	BUY	$1.12 - $3.73 $175,078 - $583,073	156,320 Added 32.97%	630,400 $1.92 Million
Q3 2023 Nov 14, 2023	SELL	$1.22 - $2.67 $119,207 - $260,888	-97,711 Reduced 17.09%	474,080 $683,000
Q2 2023 Aug 11, 2023	BUY	$2.46 - $3.14 $316,887 - $404,482	128,816 Added 29.08%	571,791 $1.42 Million
Q1 2023 May 12, 2023	SELL	$2.57 - $8.16 $524,601 - $1.67 Million	-204,125 Reduced 31.54%	442,975 $1.19 Million

Q4 2022 Feb 13, 2023	BUY	$5.19 - $13.5 $2.83 Million - $7.35 Million	544,700 Added 531.93%	647,100 $3.51 Million
Q3 2022 Nov 14, 2022	SELL	$5.17 - $16.99 $1.87 Million - $6.14 Million	-361,600 Reduced 77.93%	102,400 $1.28 Million
Q2 2022 Aug 12, 2022	BUY	$4.04 - $8.51 $1.87 Million - $3.95 Million	464,000 New	464,000 $2.29 Million
Q2 2021 Aug 13, 2021	SELL	$19.57 - $26.32 $2.08 Million - $2.79 Million	-106,100 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$17.58 - $32.59 $1.87 Million - $3.46 Million	106,100 New	106,100 $2.55 Million
Q2 2019 Aug 12, 2019	SELL	$16.03 - $31.1 $1.13 Million - $2.2 Million	-70,700 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$14.4 - $21.45 $1.02 Million - $1.52 Million	70,700 New	70,700 $1.17 Million

Others Institutions Holding GTHX

# of Institutions

Shares Held

14.7M

Call Options Held

631K

Put Options Held

347K

View Full List

About G1 Therapeutics, Inc.

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $97.5M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

More about GTHX

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account